PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.36 +0.01 (+1.49%)
At close: Oct 23, 2026 · 4:00 PM EDT

PharmaCyte Biotech (PMCB) EBIT Margin (2010 - 2012)

Updated

PharmaCyte Biotech (PMCB) recorded EBIT Margin of -13851.65% in FY2013 (year ended Apr 30, 2013), down 10923.11 percentage points from -2928.55% in FY2012.

Analysis

PharmaCyte Biotech (PMCB) EBIT Margin (2010 - 2012) Analysis & Trends

  • Per Business Quant data, PMCB's EBIT Margin was -2928.55% in FY2012 (-2620.32 pp) and -308.23% in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 24.35%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 37.86%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -3.52%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 20.57%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 28.37%
10 PharmaCyte Biotech 3.87 Mn -68.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2012 -5,547.89%
Jul 31, 2012 -8,131.39%
Apr 30, 2012 -7,227.51%
Jan 31, 2012 -2,022.51%
Oct 31, 2011 -2,034.52%
Jul 31, 2011 -3,302.30%
Apr 30, 2011 -432.24%
Jan 31, 2011 -214.77%
Oct 31, 2010 -120.85%
Jul 31, 2010 -294.27%
API Access

PharmaCyte Biotech EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=PMCB&period=max&api_key=YOUR_API_KEY